Cargando…
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
INTRODUCTION: Antibodies to SARS-CoV-2 serve as critical diagnostic markers for determining how broadly the COVID-19 pandemic has spread, confirming patient recovery, monitoring potential long-term effects of infection, and evaluating potential protection from reinfection. As new antibody tests beco...
Autores principales: | Batra, Rahul, Olivieri, Luis Gonzalez, Rubin, Delfin, Vallari, Ana, Pearce, Sandra, Olivo, Ana, Prostko, John, Nebbia, Gaia, Douthwaite, Sam, Rodgers, Mary, Cloherty, Gavin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493757/ https://www.ncbi.nlm.nih.gov/pubmed/32961429 http://dx.doi.org/10.1016/j.jcv.2020.104645 |
Ejemplares similares
-
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect
por: Maine, Gabriel N., et al.
Publicado: (2020) -
Longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population
por: Interiano, Cristina, et al.
Publicado: (2021) -
Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay
por: Hamilton, Fergus, et al.
Publicado: (2020) -
Dataset for longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population divided by age
por: Interiano, Cristina, et al.
Publicado: (2021) -
Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
por: Lau, C.S., et al.
Publicado: (2021)